AR and urinary bladder carcinoma: Given the association of AR with bladder cancer, Wu et al. used a whole-exome sequencing approach to analyze a 99-patient cohort and did not detect any somatic AR mutations in any of the patients, which suggests that while the AR is often expressed in bladder cancer, AR mutation is not a key event driving bladder carcinogenesis [20].